Market Overview - In 2025, the majority of industry sectors in A-shares experienced gains, with non-ferrous metals leading at a 94.73% increase, followed by communications at 84.75% and electronics at 47.88% [1][10] - The A-share market welcomed a strong start in 2026, with the Shanghai Composite Index breaking through the previous high of 4034 points, indicating a bullish trend [2][12] - The total trading volume exceeded 2.8 trillion yuan, reflecting a robust market sentiment and increased participation from investors [2][12] Sector Performance - The insurance and financial sectors were significant contributors to the market rally, with insurance premiums reaching 57.629 billion yuan in the first 11 months of 2025, marking a 7.6% year-on-year increase [7][8] - The energy metals, solar equipment, and wind power sectors showed strong activity, driven by ongoing global initiatives towards carbon neutrality and supportive government policies [9][10] Investment Strategy - Despite the upward trend, caution is advised as profit-taking may lead to market corrections; investors are encouraged to wait for pullbacks to enter positions [3][11] - The report emphasizes the importance of focusing on companies with strong earnings to navigate market uncertainties, suggesting a preference for sectors like technology (semiconductors, AI) and cyclical industries (solar, chemicals) [3][11]

博济医药（300404.SZ）1月7日在投资者互动平台表示，公司是一家专业的CRO服务提供商，主要为医 药企业提供药品、医疗器械的研发外包服务并收取技术服务费。公司在脑科学领域积累了丰富的经验， 服务的脑科类药物有治疗脑梗、阿尔兹海默、帕金森等项目；脑科类医疗器械由控股子公司九泰药械提 供服务，如植入式脑深部刺激系统、磁刺激调控治疗抑郁症、无创脑神经刺激器治疗抑郁症等项目。 （文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：目前贵公司是否有为脑科及人脑工程领域药物、脑神 经科学方面的医疗器械提供临床研究服务。有媒体报道贵公司子公司九泰药械目前有为诸如植入式脑深 部刺激系统、磁刺激调控治疗抑郁症等脑神经科学方面的医疗器械提供临床研究服务，消息是否属实？ ...

(本文来自第一财经) 翔宇医疗发布异动公告称，近期资本市场对人脑工程、脑机接口等概念关注度较高，相关板块股价涨幅 较大。公司目前主要聚焦非侵入式脑机接口技术，覆盖作业疗法、运动疗法、认知言语、吞咽等康复全 场景布局，与当前国际上的侵入式脑机接口技术路线存在差异。公司在脑机接口方面的投入，目前在技 术、产品、渠道市场等方面形成一定的布局，但招投标和销售等具有滞后性，截至2025年末，相关产品 尚未实现规模化销售，营收占比较小。 ...

写在文章前的声明：在本文之前的说明：本文中所列的投资信息，只是一个对基金资产净值进行排行的客观描述，并无主观倾向性，也不是投资建议，纯属 娱乐性质。 一顿操作猛如虎，基金净值已更新，谁是基金中的王者，谁又垫底，请看数据： | 基金简称 PK | | | 最新净在线 手段时间原因人 | | | --- | --- | --- | --- | --- | | 1 | 华银健康生 ... 置 | 1.3730 | 6.77% | 8 | | | 001056 | 2026-1-6 | | | | 2 | 金鹰周期优 ... A | 0.8175 | 6.56% | 8 | | | 004211 | 2026-1-6 | | | | 3 | 金鹰周期优 ... C | 0.8063 | 6.55% | 8 | | | 019748 | 2026-1-6 | | | | 4 | 东财景气驱 ... C | 1.6351 | 6.35% | | | | 019144 | 2026-1-6 | | | | 5 | 东财景气驱...A | 1.6549 | 6.35% | | | | 019143 | 2026-1-6 | ...

Market Overview - A-shares continued to rise strongly, with the Shanghai Composite Index achieving a 13-day winning streak and reaching a 10-year high, closing at 4083.67 points, up 1.5% [2] - The total trading volume in the A-share market exceeded 2.8 trillion yuan, with over 4100 stocks gaining, and more than 140 stocks hitting the daily limit [2] - The Hong Kong stock market also saw gains, with both major indices rising over 1% [2] Financial Sector Performance - The insurance sector saw significant gains, with New China Life Insurance rising over 6% and China Pacific Insurance up more than 5%, both reaching historical highs [3] - The recovery in long-term interest rates, with the 10-year government bond yield exceeding 1.8%, is expected to drive valuation recovery in the insurance sector [3] - The brokerage sector also performed strongly, with Huahlin Securities and Huatai Securities hitting the daily limit, and Dongfang Fortune rising nearly 6% [3] Commodity Sector Insights - The non-ferrous metals sector experienced a collective surge, particularly cobalt and nickel stocks, with companies like Chang Aluminum and Xiyuan Mining hitting the daily limit [6] - Zijin Mining reached a historical high, closing up over 6% with a trading volume of 131.9 billion yuan [6] Autonomous Driving Sector - The autonomous driving concept saw a significant rise, with Hanxin Technology hitting the daily limit of 30%, and Wanji Technology and Leirwei both reaching 20% gains [8] - NVIDIA's release of an open-source AI model aimed at enhancing autonomous driving technology is expected to stimulate demand for self-driving taxis and support global economic growth [9][10] Future Outlook - Analysts predict that 2026 will be a pivotal year for advanced driving technologies, with expectations for breakthroughs in policies, user acceptance, and business models [10]

13连阳的市场我们该如何操作呢？和讯投顾孔晓云分析称，今天大盘量能再一次出现了大幅放大，收盘 更是站在最高点两个字，追高当然是不要的，因为我们早已做好埋伏。 今天的盘面已经超越昨天的趋势了，板块之间轮动上涨，资金方面雨露均沾，盘面良好发展，但一直这 样下去也不可能的，所以从指数层面会有阴线出现，但阴线实体不会很大，因为资金还在进行下一步的 抢筹，主线方向出现回落，考虑做加法即可。板块方面，人脑工程、商业航天、智能驾驶、机器人等今 天继续走强，市场最近一直在围绕着老马的言论进行炒作，从市场情绪面看，短期没有结束的迹象可以 继续格局，记住只低吸不追高，但短期冲高后期还是会回调，回落也是下一个阶段的机会。 有色金属板块今天强势崛起，消息面上有地缘冲突，再起引发了晚间黄金白银等有色期货大涨。总的原 则就是证券扛下棋情绪回归，盘面健康，继续躺平不动。 ...

格隆汇1月6日丨翔宇医疗(688626.SH)公布，近期资本市场对人脑工程、脑机接口等概念关注度较高， 相关板块股价涨幅较大。公司目前主要聚焦非侵入式脑机接口技术，覆盖作业疗法、运动疗法、认知言 语、吞咽等康复全场景布局，与当前国际上的侵入式脑机接口技术路线存在差异。公司在脑机接口方面 的投入，目前在技术、产品、渠道市场等方面形成一定的布局，但招投标和销售等具有滞后性，截至 2025年末，相关产品尚未实现规模化销售，营收占比较小。 ...

Core Viewpoint - The company, Xiangyu Medical, has noted increased market attention on brain engineering and brain-machine interface concepts, leading to significant stock price increases in related sectors [1] Company Focus - The company primarily focuses on non-invasive brain-machine interface technology, which encompasses a comprehensive rehabilitation layout including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-machine interface technologies [1] Market Position and Development - The company has made investments in brain-machine interface technology, establishing a certain level of layout in technology, products, and market channels [1] - However, the company faces delays in bidding and sales processes, with related products not expected to achieve large-scale sales until the end of 2025, resulting in a small revenue contribution [1]

Group 1 - The core point of the article is that Xiangyu Medical (688626) has experienced a significant stock price fluctuation, with a cumulative increase of 30% over three consecutive trading days, triggering an abnormal trading alert according to stock exchange regulations [1] - The recent surge in interest in brain engineering and brain-computer interface concepts has positively impacted the stock prices in this sector, including Xiangyu Medical, which focuses on non-invasive brain-computer interface technology [1] - Xiangyu Medical's current technology and product development in brain-computer interfaces cover various rehabilitation scenarios, but the company acknowledges that its products are not expected to achieve large-scale sales until the end of 2025, resulting in a small revenue contribution at this time [1] Group 2 - The stock price of Xiangyu Medical reached a closing price of 87.12 yuan per share on January 6, with a 20% increase on that day, following two consecutive days of trading limits [1]

Core Viewpoint - The stock of Xiangyu Medical has experienced significant volatility, with a cumulative price deviation of 30% over three consecutive trading days, attributed to heightened market interest in brain engineering and brain-computer interface concepts [1] Company Focus - The company is primarily focused on non-invasive brain-computer interface technology, which encompasses a comprehensive range of rehabilitation scenarios including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-computer interface technologies [1] Market Position and Development - The company has made investments in brain-computer interface technology, establishing a certain level of layout in technology, products, and market channels [1] - However, the bidding and sales processes exhibit a lag, and as of the end of 2025, related products are not expected to achieve large-scale sales, resulting in a relatively small revenue contribution [1]